News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Boxer Capital, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/19/2022 |
SC 13G
| Boxer Capital, LLC reports a 5.7% stake in SpringWorks Therapeutics, Inc. |
| 07/09/2021 |
SC 13G
| Boxer Capital, LLC reports a 5.9% stake in Elevation Oncology, Inc. |
| 05/17/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/30/2021 |
SC 13G
| Boxer Capital, LLC reports a 7.3% stake in Biomea Fusion, Inc. |
| 02/26/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/20/2021 |
SC 13G
| Boxer Capital, LLC reports a 5.6% stake in Merus N.V. |
| 12/17/2020 |
SC 13G
| Boxer Capital, LLC reports a 4.8% stake in Silverback Therapeutics, Inc. |
| 09/30/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/24/2020 |
SC 13G
| Boxer Capital, LLC reports a 5.8% stake in CymaBay Therapeutics, Inc. |
| 08/03/2020 |
SC 13G
| Boxer Capital, LLC reports a 7.2% stake in Milestone Pharmaceuticals Inc. |
| 07/20/2020 |
SC 13G
| Boxer Capital, LLC reports a 8.8% stake in Therapeutics Acquisition Corp. |
| 06/29/2020 |
SC 13G
| Boxer Capital, LLC reports a 7.8% stake in IDEAYA Bioscience, Inc. |
| 05/11/2020 |
SC 13G
| Boxer Capital, LLC reports a 7.6% stake in Syndax Pharmaceuticals, Inc. |
| 03/02/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2020 |
SC 13G
| Boxer Capital, LLC reports a 5.6% stake in Revolution Medicines, Inc. |
| 02/13/2020 |
SC 13G
| Boxer Capital, LLC reports a 5.6% stake in Black Diamond Therapeutics, Inc. |
| 02/13/2020 |
SC 13G
| Boxer Capital, LLC reports a 6.6% stake in Arcus Biosciences, Inc. |
| 02/03/2020 |
SC 13G
| Boxer Capital, LLC reports a 5.9% stake in Trillium Therapeutics Inc. |
| 12/13/2019 |
SC 13G
| Boxer Capital, LLC reports a 6% stake in Marinus Pharmaceuticals, Inc. |
| 11/07/2019 |
SC 13G
| Boxer Capital, LLC reports a 9.1% stake in Cabaletta Bio, Inc. |
| 08/26/2019 |
SC 13G
| Boxer Capital, LLC reports a 10% stake in Bellicum Pharmaceuticals, Inc. |
| 07/01/2019 |
SC 13G
| Boxer Capital, LLC has filed a Schedule 13D for Atreca, Inc. |
| 05/28/2019 |
SC 13G
| Boxer Capital, LLC reports a 10% stake in Cellectar Biosciences Inc. |
| 12/31/2018 |
SC 13G
| Boxer Capital, LLC reports a 7.5% stake in DBV Technologies S.A. |
| 11/08/2018 |
SC 13G
| Boxer Capital, LLC reports a 7% stake in Matinas BioPharma Holdings, Inc. |
| 06/29/2018 |
SC 13G
| Boxer Capital, LLC reports a 5.5% stake in Wave Life Sciences Ltd. |
| 05/18/2018 |
SC 13G
| Boxer Capital, LLC reports a 6.2% stake in Solid Biosciences Inc. |
| 05/11/2018 |
SC 13G
| Boxer Capital, LLC reports a 9.6% stake in ESPERION THERAPEUTICS, INC. |
| 04/23/2018 |
SC 13G
| Boxer Capital, LLC reports a 2.6% stake in Rigel Pharmaceuticals, Inc. |
| 03/05/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/20/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/26/2018 |
SC 13G
| Boxer Capital, LLC reports a 6% stake in PTC THERAPEUTICS, INC. |
| 01/19/2018 |
SC 13G
| Boxer Capital, LLC reports a 5.3% stake in ROCKET PHARMACEUTICALS, INC. |
|
|
|